Nesfatin-1 attenuates renal interstitial fibrosis, oxidative stress, and inflammation through dual suppression of TGF-β1/Smad and NF-κB/GPR12 signaling
Fields of Study & Subjects
Chronic Kidney Disease and Diabetes
Parathyroid Disorders and Treatments
Diabetes Treatment and Management
Publication details
- Journal / source
- Biochemical Pharmacology
- Publisher
- Elsevier BV
- Volume
- 249
- Pages
- 117894–117894
- Publication date
- 15 March 2026
- Language
- EN